---
content_type: page
description: This section provides the list of readings assigned for each session
  of the course.
draft: false
learning_resource_types:
- Readings
ocw_type: CourseSection
title: Readings
uid: 0fc55b90-bb78-526d-b6b3-5e0b633f870c
---
{{< tableopen >}}{{< theadopen >}}{{< tropen >}}{{< thopen >}}
SES #
{{< thclose >}}{{< thopen >}}
Topics
{{< thclose >}}{{< thopen >}}
READINGS
{{< thclose >}}{{< trclose >}}{{< theadclose >}}{{< tbodyopen >}}{{< tropen >}}{{< tdopen colspan="3" >}}
**Fall 2005**
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
1
{{< tdclose >}}{{< tdopen >}}

Authorship

*Speaker*

Dr. Julie Ingelfinger, Professor of Pediatrics, Harvard Medical School and Deputy Editor, New England Journal of Medicine

{{< tdclose >}}{{< tdopen >}}

Drazen, Jeffrey M., and Gregory D. Curfman. "On Authors and Contributors." *N Engl J Mcd* 347 (2002): 55.

Kempers, R. D. "Ethical issues in biomedical publications." *Fertil Steril* 77 (2002): 883-888.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
2
{{< tdclose >}}{{< tdopen >}}

Ethical and Professional Conduct Issues in Engineering Breakthrough Medical Technologies

*Speaker*

John Abele, founder and Chairman of Boston Scientific Corporation

{{< tdclose >}}{{< tdopen >}}

Hashimoto, H., et al. "The diffusion of medical technology, local conditions, and technology re-invention: A comparative case study on coronary stenting." *Health Policy* (February 10, 2006). \[e-pub ahead of print.\]

Libeer, J. C. "Role of external quality assurance schemes in assessing and improving quality in medical laboratories." *Clin Chim Acta* 309 (2001): 173-177.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
3
{{< tdclose >}}{{< tdopen >}}

HST Graduate Program Design and Administration

*Speaker* 

Dr. Sangeeta Bhatia, an HST Graduate and Recent Addition to the Faculty at HST

{{< tdclose >}}{{< tdopen >}}
National Academy of Sciences. Committee on Science, Engineering, and Public Policy. *On Being a Scientist: Responsible Conduct in Research*. Washington, DC: National Academy Press, 1995.
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
4
{{< tdclose >}}{{< tdopen >}}

Case Studies on Funding Ethical Issues in Academia and the Clinic

*Speaker*

Dr. John Parrish, Chairman of Dermatology for the Harvard Teaching Hospitals, Founder and Former Director of the Wellman Labs for PhotoMedicine, and Founder and Director of the Center for the Integration of Medicine and Innovative Technology (CIMIT)

{{< tdclose >}}{{< tdopen >}}

Chadwick, R., and U. Schuklenk. "Sleeping with the enemy? Where to draw the line on research funding?" *Bioethics* 19 (2005): iii-iv.

Cichy, K. A. "Ethical implications of for-profit corporate sponsorship of research." *SRA J* 22 (1990): 23-27.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
5
{{< tdclose >}}{{< tdopen >}}

Ethical Dilemmas Associated with Drug Development for Small Target Groups

*Speaker*

Dave Fleming, Senior VP of Genzyme

{{< tdclose >}}{{< tdopen >}}

Gericke, C. A., A. Riesberg, and R. Busse. "Ethical issues in funding orphan drug research and development." *J Med Ethics* 31 (2005): 164-168.

Hughes, D. A., B. Tunnage., and S. T. Yeo. "Drugs for exceptionally rare diseases: do they deserve special status for funding?" *QJM* 98 (2005): 829-836.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
6
{{< tdclose >}}{{< tdopen >}}

Ethical Issues Related to Clinical Research in High Stress Environments

*Speaker* 

Kris Olson, MD

{{< tdclose >}}{{< tdopen >}}
Bjerneld, M., et al. "Perceptions of work in humanitarian assistance: interviews with returning Swedish health professionals." *Disaster Manag Response* 2 (2004): 101-108.
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen colspan="3" >}}
**Spring 2006**
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
7
{{< tdclose >}}{{< tdopen >}}

Ethics of Closed-loop Medical Control Systems

*Speaker*

Prof. John Guttag, Senior Professor of Electrical Engineering and Computer Science at MIT

{{< tdclose >}}{{< tdopen >}}
Shoeb, A., et al. "Patient-specific seizure onset detection." *Epilepsy Behav* 5 (2004): 483-498.
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
8
{{< tdclose >}}{{< tdopen >}}

Ethics of Pharmaceutical Post-market Surveillance

*Speaker*

Dr. Frank Douglas, Executive Director of the Center for Biomedical Innovation Management, MIT

{{< tdclose >}}{{< tdopen >}}
Abraham, J., and C. Davis. "A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy." *Soc Sci Med* 61 (2005): 881-892.
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
9
{{< tdclose >}}{{< tdopen >}}

Ethical Considerations in Accelerating Medical Technologies

*Speaker*

Dr. Wendy Everett, President of the New England Healthcare Institute (NEHI)

{{< tdclose >}}{{< tdopen >}}
 
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
10
{{< tdclose >}}{{< tdopen >}}

Ethics of Live-sustaining Biomedical Engineering Design

*Speaker*

Dr. David Lederman, Founder and Former Chairman of ABIOMED

{{< tdclose >}}{{< tdopen >}}
 
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
11
{{< tdclose >}}{{< tdopen >}}

The Good Works Project and Ethical Conduct of Research

*Speaker*

Dr. Howard Gardner, John H. and Elisabeth A. Hobbs Professor of Cognition and Education at the Harvard Graduate School of Education

{{< tdclose >}}{{< tdopen >}}
 
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
12
{{< tdclose >}}{{< tdopen >}}
The Ethics of Genetic Screening for Therapeutic Procedures
{{< tdclose >}}{{< tdopen >}}
 
{{< tdclose >}}{{< trclose >}}{{< tbodyclose >}}{{< tableclose >}}